SEC Filing Details

SEC Filing Details

Document Details

Form
DEFM14A
Filing Date
Apr 13, 2021
Document Date
Apr 13, 2021
Form Description
Definitive proxy statement relating to merger or acquisition
Filing Group
Mergers & Acquisitions
Company
ReShape Lifesciences
Issuer
For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE